FDA Clearance and CL...
1st February 2023 Product update: rapidmicrobiology staff writer
MAESTRIA™, a New Generation Microbiology Middleware Optimizes Laboratory Workflow
bioMérieux has launched MAESTRIATM a new generation middleware for the clinical microbiology laboratory that aims at providing a central software tool for the workflow management of all routine activities.
With automation and digitalization of diagnostic solutions, clinical microbiology laboratories need to handle more and more medical data along the healthcare pathway. They require specific software solutions to help manage the growing needs for workflow optimization, biological expertise and data management. Managing workload in a timely manner and ensuring the quality of the testing workflow are everyday challenges in order to assist the various health professionals in their decision-making process for optimizing patient care.
The Central Tool for the Management of Routine Activities in Microbiology
MAESTRIA™ is the new generation microbiology middleware from bioMérieux, managing specimens from the moment they are logged into the laboratory workflow until the final testing results are available.
This software with a state-of-the-art graphical user interface covers various workflow steps including staining results or manual input of offline Antimicrobial Susceptibility Testing (AST) results, in addition to all connectable instruments. MAESTRIA™ also allows to define customer-specific AST interpretation rules, merging results from multiple methods - either online or manual - to consolidate
one final antibiogram.
Thanks to the additional CLARION™ Lab Analytics module, a data visualization feature, MAESTRIA™ transforms data into real-time, easy-to-access and actionable insights.
A Solution Created by Microbiologists for Microbiologists
MAESTRIA™ was designed and developed to meet users’ expectations, collected through years of experience in the field of microbiology middleware, and iteratively approved by a number of clinical microbiology laboratories worldwide.
Already available for a number of pilot sites, MAESTRIA™ is being progressively launched globally through 2023. Customer feedback helps demonstrate the value of MAESTRIATM in the lab routine and also provides broader workflow coverage and new features through continuous improvement.
Date Published: 1st February 2023
Source article link: View
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.
VIDAS® KUBE™ -
FDA Clearance and CLIA-waiver for